Surginex

Provider of AI-based drug discovery platform

placeSeoul, Seoul, South Korea calendar_todayFounded 2020 groups6 employees language surginex.com

Innovation

14 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 64 times.

YearFilings
20223
20246
20256

Investor mix

6 investors on record.

Investor typeCountShare
Other / undisclosed6100%
Coming soon